These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31015296)

  • 1. Toward personalized cognitive diagnostics of at-genetic-risk Alzheimer's disease.
    Coughlan G; Coutrot A; Khondoker M; Minihane AM; Spiers H; Hornberger M
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9285-9292. PubMed ID: 31015296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-retest reliability of spatial navigation in adults at-risk of Alzheimer's disease.
    Coughlan G; Puthusseryppady V; Lowry E; Gillings R; Spiers H; Minihane AM; Hornberger M
    PLoS One; 2020; 15(9):e0239077. PubMed ID: 32960930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional connectivity between the entorhinal and posterior cingulate cortices underpins navigation discrepancies in at-risk Alzheimer's disease.
    Coughlan G; Zhukovsky P; Puthusseryppady V; Gillings R; Minihane AM; Cameron D; Hornberger M
    Neurobiol Aging; 2020 Jun; 90():110-118. PubMed ID: 32171591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.
    Bondi MW; Salmon DP; Galasko D; Thomas RG; Thal LJ
    Psychol Aging; 1999 Jun; 14(2):295-303. PubMed ID: 10403716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's disease.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Xu L; Zhang Z
    Oncotarget; 2016 Sep; 7(37):58789-58801. PubMed ID: 27542235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial navigation and APOE in amnestic mild cognitive impairment.
    Laczó J; Andel R; Vlček K; Macoška V; Vyhnálek M; Tolar M; Bojar M; Hort J
    Neurodegener Dis; 2011; 8(4):169-77. PubMed ID: 21124005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced grid-cell-like representations in adults at genetic risk for Alzheimer's disease.
    Kunz L; Schröder TN; Lee H; Montag C; Lachmann B; Sariyska R; Reuter M; Stirnberg R; Stöcker T; Messing-Floeter PC; Fell J; Doeller CF; Axmacher N
    Science; 2015 Oct; 350(6259):430-3. PubMed ID: 26494756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM
    Neurobiol Aging; 2019 Apr; 76():162-165. PubMed ID: 30716541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
    Konishi K; Joober R; Poirier J; MacDonald K; Chakravarty M; Patel R; Breitner J; Bohbot VD
    J Alzheimers Dis; 2018; 61(4):1493-1507. PubMed ID: 29278888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA; Hermann B; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
    J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
    Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.